Literature DB >> 19088123

Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.

Amy L Akers1, Eric Johnson, Gary K Steinberg, Joseph M Zabramski, Douglas A Marchuk.   

Abstract

Cerebral cavernous malformations (CCMs) are vascular anomalies of the central nervous system, comprising dilated blood-filled capillaries lacking structural support. The lesions are prone to rupture, resulting in seizures or hemorrhagic stroke. CCM can occur sporadically, manifesting as solitary lesions, but also in families, where multiple lesions generally occur. Familial cases follow autosomal-dominant inheritance due to mutations in one of three genes, CCM1/KRIT1, CCM2/malcavernin or CCM3/PDCD10. The difference in lesion burden between familial and sporadic CCM, combined with limited molecular data, suggests that CCM pathogenesis may follow a two-hit molecular mechanism, similar to that seen for tumor suppressor genes. In this study, we investigate the two-hit hypothesis for CCM pathogenesis. Through repeated cycles of amplification, subcloning and sequencing of multiple clones per amplicon, we identify somatic mutations that are otherwise invisible by direct sequencing of the bulk amplicon. Biallelic germline and somatic mutations were identified in CCM lesions from all three forms of inherited CCMs. The somatic mutations are found only in a subset of the endothelial cells lining the cavernous vessels and not in interstitial lesion cells. These data suggest that CCM lesion genesis requires complete loss of function for one of the CCM genes. Although widely expressed in the different cell types of the brain, these data also suggest a unique role for the CCM proteins in endothelial cell biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088123      PMCID: PMC2640209          DOI: 10.1093/hmg/ddn430

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

1.  Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients.

Authors:  Valeria Marini; Loretta Ferrera; Francesca Pigatto; Paola Origone; Cecilia Garrè; Alessandra Dorcaratto; Giuseppe Viale; Francesco Alberti; Cristina Mareni
Journal:  Am J Med Genet A       Date:  2004-09-15       Impact factor: 2.802

2.  Somatic mutations--not just for cancer anymore.

Authors:  Jennifer M Puck; Stephen E Straus
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

3.  Interaction of the integrin beta1 cytoplasmic domain with ICAP-1 protein.

Authors:  X A Zhang; M E Hemler
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

4.  Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.

Authors:  S Laberge-le Couteulx; H H Jung; P Labauge; J P Houtteville; C Lescoat; M Cecillon; E Marechal; A Joutel; J F Bach; E Tournier-Lasserve
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

5.  Cerebral cavernous malformations. Incidence and familial occurrence.

Authors:  D Rigamonti; M N Hadley; B P Drayer; P C Johnson; K Hoenig-Rigamonti; J T Knight; R F Spetzler
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

6.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Natural history of the cavernous angioma.

Authors:  J R Robinson; I A Awad; J R Little
Journal:  J Neurosurg       Date:  1991-11       Impact factor: 5.115

9.  An analysis of the natural history of cavernous angiomas.

Authors:  O Del Curling; D L Kelly; A D Elster; T E Craven
Journal:  J Neurosurg       Date:  1991-11       Impact factor: 5.115

10.  Assignment of a locus for dominantly inherited venous malformations to chromosome 9p.

Authors:  L M Boon; J B Mulliken; M Vikkula; H Watkins; J Seidman; B R Olsen; M L Warman
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

View more
  110 in total

Review 1.  Recent advances in vascular development.

Authors:  Courtney K Domigan; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

2.  Phosphorylation sites in the cerebral cavernous malformations complex.

Authors:  Jaehong Kim; Nicholas E Sherman; Jay W Fox; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2011-12-01       Impact factor: 5.285

Review 3.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

Review 4.  Evaluating strategies for the treatment of cerebral cavernous malformations.

Authors:  Dean Y Li; Kevin J Whitehead
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

5.  Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice.

Authors:  Aubrey C Chan; Stavros G Drakos; Oscar E Ruiz; Alexandra C H Smith; Christopher C Gibson; Jing Ling; Samuel F Passi; Amber N Stratman; Anastasia Sacharidou; M Patricia Revelo; Allie H Grossmann; Nikolaos A Diakos; George E Davis; Mark M Metzstein; Kevin J Whitehead; Dean Y Li
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

Review 6.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

7.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

8.  Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Authors:  Angela J Glading; Mark H Ginsberg
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

9.  Two-hit mechanism in cerebral cavernous malformation? A case of monozygotic twins with a CCM1/KRIT1 germline mutation.

Authors:  Philipp Dammann; Ute Hehr; Sabine Weidensee; Yuan Zhu; Rüdiger Gerlach; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2013-04-13       Impact factor: 3.042

10.  Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.

Authors:  Matthew R Detter; Daniel A Snellings; Douglas A Marchuk
Journal:  Circ Res       Date:  2018-10-26       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.